le lundi 23 juillet 2018, à 01:58. Posté
par Behappy
I work here http://www.demirdokumservispendik.com/renew-biopharma-stock-59fe.pdf renew biopharma stock "Higher costs, exploration charges, adverse currency exchange rate effects and challenges in Nigeria have hit our bottom line," said Voser, who is due to retire and be replaced by downstream chief Ben van Beurden at the end of this year. "These results were undermined by a number of factors - but they were clearly disappointing for Shell."